We are pleased to announce that we will exhibit at BioJapan 2026 held at PACIFICO Yokohama from October 7 to 9, 2026.
During the event, we will be presenting information on our NTX-083, Alzheimer’s disease drug candidate, at Booth B-76.
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2026
Company Overview
・ Established: April 2022
・ Location: 3-11-5 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan
・ Representative Director: Itaru Arimoto, Ph.D.
・ Business activities: Research and development of treatments for dementia and psychiatric disorders, exploration of early-stage drug discovery for brain diseases
・ Website: https://neusignal-tx.com/
